Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Boehringer Ingelheim
AstraZeneca
McKinsey
Merck

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ESMOLOL HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

ESMOLOL HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386 NDA Baxter Healthcare Corporation 10019-055-61 10 BAG in 1 CARTON (10019-055-61) > 250 mL in 1 BAG
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386 NDA Baxter Healthcare Corporation 10019-075-87 10 BAG in 1 CARTON (10019-075-87) > 100 mL in 1 BAG
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386 NDA Baxter Healthcare Corporation 10019-115-01 25 VIAL in 1 CARTON (10019-115-01) > 10 mL in 1 VIAL (10019-115-39)
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386 NDA Baxter Healthcare Corporation 10019-120-01 25 VIAL in 1 CARTON (10019-120-01) > 10 mL in 1 VIAL (10019-120-39)
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386 NDA Baxter Healthcare Corporation 10019-666-10 10 BAG in 1 CARTON (10019-666-10) > 100 mL in 1 BAG
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386 NDA Baxter Healthcare Corporation 10019-668-10 10 BAG in 1 CARTON (10019-668-10) > 100 mL in 1 BAG
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386 NDA Baxter Healthcare Corporation 10019-670-10 10 BAG in 1 CARTON (10019-670-10) > 250 mL in 1 BAG
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Harvard Business School